Evaluating the impact of hydroxychloroquine on mouse lymphocyte proliferation and cytokine production in vivo and in vitro

by Simon Wabitsch, Justin D. McCallen, Chi Ma, Tim F. Greten
Published 2021-06-01

Can GPR4 Be a Potential Therapeutic Target for COVID-19?

by Li V. Yang, Li V. Yang, Karen A. Oppelt, Mary Jane Thomassen, Mona A. Marie, Shayan Nik Akhtar, Justin D. McCallen
Published 2021-01-01

Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition

by Abdul Rafeh Naqash, Ebenezer Appah, Li V. Yang, Mahvish Muzaffar, Mona A. Marie, Justin D. Mccallen, Shravanti Macherla, Darla Liles, Paul R. Walker
Published 2019-07-01

Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models

by Simon Wabitsch, John C. McVey, Chi Ma, Benjamin Ruf, Olena Kamenyeva, Justin D. McCallen, Laurence P. Diggs, Bernd Heinrich, Tim F. Greten
Published 2021-01-01

Anti–PD-1 in Combination With Trametinib Suppresses Tumor Growth and Improves Survival of Intrahepatic Cholangiocarcinoma in MiceSummary

by Simon Wabitsch, Mayank Tandon, Benjamin Ruf, Qianfei Zhang, Justin D. McCallen, John C. McVey, Chi Ma, Benjamin L. Green, Laurence P. Diggs, Bernd Heinrich, Tim F. Greten
Published 2021-01-01

Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting

by Melissa Y.Y. Moey, MD, MSc, Anna N. Tomdio, MD, Justin D. McCallen, BSc, Lauren M. Vaughan, MD, Kevin O’Brien, PhD, Abdul R. Naqash, MD, Cynthia Cherry, RN, ANP, Paul R. Walker, MD, Blase A. Carabello, MD
Published 2020-09-01